Tri Chemical Laboratories (FRA:22E) Cyclically Adjusted Revenue per Share: €2.19 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:22E Tri Chemical Laboratories Inc FRA:22E
93 GF Score
Price €16.20
GF Value €27.01
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Tri Chemical Laboratories Cyclically Adjusted Revenue per Share?

Tri Chemical Laboratories FRA:22E -8.99% 93 Cyclically Adjusted Revenue per Share is €2.19 as of Apr. 2026. GuruFocus rates FRA:22E with a GF Score™ of 93/100 and a GF Value™ of €27.01 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Tri Chemical Laboratories's adjusted revenue per share for the three months ended in Apr. 2026 was €1.238. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €2.19 for the trailing ten years ended in Apr. 2026.

During the past 12 months, Tri Chemical Laboratories's average Cyclically Adjusted Revenue Growth Rate was 17.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 16.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 15.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Tri Chemical Laboratories was 16.30% per year. The lowest was 11.70% per year. And the median was 13.80% per year.

As of today (2026-07-29), Tri Chemical Laboratories's current stock price is €16.20. Tri Chemical Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Apr. 2026 was €2.19. Tri Chemical Laboratories's Cyclically Adjusted PS Ratio of today is 7.40.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Tri Chemical Laboratories was 23.61. The lowest was 6.12. And the median was 10.25.


Tri Chemical Laboratories  (FRA:22E) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Tri Chemical Laboratories's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=16.20/2.19
=7.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Tri Chemical Laboratories was 23.61. The lowest was 6.12. And the median was 10.25.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Tri Chemical Laboratories Cyclically Adjusted Revenue per Share Related Terms


Tri Chemical Laboratories Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Tri Chemical Laboratories's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tri Chemical Laboratories Cyclically Adjusted Revenue per Share Chart

Tri Chemical Laboratories Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1.74 1.70 2.05 2.13

Tri Chemical Laboratories Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.14 2.14 2.11 2.13 2.19

FRA:22E vs LIN, SHW, ECL: Cyclically Adjusted Revenue per Share Comparison

For the Specialty Chemicals subindustry, Tri Chemical Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tri Chemical Laboratories Cyclically Adjusted PS Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tri Chemical Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Tri Chemical Laboratories's Cyclically Adjusted PS Ratio falls into.


FRA:22E
93GF Score
Tri Chemical Laboratories Inc FRA:22E
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tri Chemical Laboratories Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Tri Chemical Laboratories's adjusted Revenue per Share data for the three months ended in Apr. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=1.238/113.0000*113.0000
=1.238

Current CPI (Apr. 2026) = 113.0000.

Tri Chemical Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201607 0.384 97.900 0.443
201610 0.371 98.600 0.425
201701 0.355 98.200 0.409
201704 0.386 98.500 0.443
201707 0.378 98.300 0.435
201710 0.407 98.800 0.465
201801 0.427 99.500 0.485
201804 0.466 99.100 0.531
201807 0.461 99.200 0.525
201810 0.489 100.200 0.551
201901 0.518 99.700 0.587
201904 0.529 100.000 0.598
201907 0.548 99.800 0.620
201910 0.525 100.400 0.591
202001 0.568 100.500 0.639
202004 0.625 100.200 0.705
202007 0.659 100.000 0.745
202010 0.654 99.800 0.741
202101 0.623 99.800 0.705
202104 0.619 99.100 0.706
202107 0.655 99.700 0.742
202110 0.741 99.900 0.838
202201 0.722 100.300 0.813
202204 0.703 101.500 0.783
202207 0.759 102.300 0.838
202210 0.763 103.700 0.831
202301 0.802 104.700 0.866
202304 0.679 105.100 0.730
202307 0.472 105.700 0.505
202310 0.505 107.100 0.533
202401 0.585 106.900 0.618
202404 0.610 107.700 0.640
202407 0.847 108.600 0.881
202410 0.967 109.500 0.998
202501 1.102 111.200 1.120
202504 1.248 111.500 1.265
202507 1.040 111.900 1.050
202510 0.984 112.800 0.986
202601 0.982 112.900 0.983
202604 1.238 113.000 1.238

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €2.19 mean?
Tri Chemical Laboratories (FRA:22E) has a Cyclically Adjusted Revenue per Share of €2.19 as of Apr. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Tri Chemical Laboratories and its competitors.
Is Tri Chemical Laboratories' Cyclically Adjusted Revenue per Share too high?
Tri Chemical Laboratories' current Cyclically Adjusted Revenue per Share is €2.19. Overall, Tri Chemical Laboratories has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tri Chemical Laboratories' Cyclically Adjusted Revenue per Share compare to LIN and SHW?
Tri Chemical Laboratories' Cyclically Adjusted Revenue per Share of €2.19 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Chemicals company?
A good Cyclically Adjusted Revenue per Share depends on the Chemicals industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Tri Chemical Laboratories and its competitors. Tri Chemical Laboratories's current Cyclically Adjusted Revenue per Share is €2.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tri Chemical Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Tri Chemical Laboratories (FRA:22E) is currently considered Significantly Undervalued. The stock's GF Value™ is €27.01, compared to a current price of €16.20 — trading 40% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €2.19. Tri Chemical Laboratories' overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Tri Chemical Laboratories (FRA:22E), the current Cyclically Adjusted Revenue per Share is €2.19 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tri Chemical Laboratories (FRA:22E) Overvalued in 2026?

Based on GuruFocus' analysis, Tri Chemical Laboratories stock appears to be undervalued. The current stock price of €16.20 is trading 40% below its estimated GF Value™ of €27.01. GuruFocus considers Tri Chemical Laboratories to be Significantly Undervalued.

Key valuation signals for FRA:22E:

  • Cyclically Adjusted Revenue per Share: €2.19
  • GF Value™: €27.01 vs. price of €16.20 (40% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the FRA:22E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tri Chemical Laboratories Business Description

Other Exchanges 4369:Japan
Address 8154-217 Uenohara, Uenohara-shi, Yamanashi, JPN, 409-0112
Tri Chemical Laboratories Inc is engaged in the manufacturing of high-purity chemical compounds for the semiconductor industry.
93GF Score

Get the complete analysis for FRA:22E

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.20
Price
€27.01
GF Value